EVOTEC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13 EUR | +8.33% |
|
-.--% | -.--% |
| 05-30 | Evotec Partners With French Institutions, Company to Research Obesity | MT |
| 05-30 | Evotec Joins Collaboration to Identify New Therapies for Obesity, Metabolic Diseases | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOTEC | Other Biotechnology & Medical Research | +8.33% | -.--% | - | - | - | 1.66B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- EVT Stock
- EVT Stock
- Charts Evotec
- Comparison Chart
